アクセプト論文 2026年

Japanese evidence on Janus kinase inhibitors for rheumatoid arthritis: a narrative review of risk-optimized use.

筆者 Haruki Matsumoto, Shuhei Yoshida, Mako Tahara, Hiroki Nibu, So Yamamoto, Takayoshi Sakamoto, Shotaro Ogawa, Kenji Saito, Yuya Sumichika, Eiji Suzuki, Tomoyuki Asano, Shuzo Sato and Yasuhiro Shimojima.
掲載誌 Front Pharmacol.17:1842268.

Methodological considerations in interpreting short-term functional gains after structured hand massage in rheumatoid arthritis.

筆者 Matsumoto H, Yamamoto S, Yoshida S, Shimojima Y.
掲載誌 Rheumatol Int. 2026 Jun 5;46(6):135.

Unmasking peripheral T-cell lymphoma in dermatomyositis with anti-PM/Scl-100 and anti-Mi-2 positivity: a case-based review.

筆者 Yamamoto S, Matsumoto H, Nibu H, Tanuma Y, Fukuchi K, Fukatsu M, Kimura S, Tahara M, Motoki Y, Tasaki K, Tsukada M, Kanno Y, Yoshida S, Saito K, Asano T, Sato S, Shimojima Y.
掲載誌 Rheumatol Int. 2026 May 25;46(6):112.

Systemic sclerosis with concurrent ANCA-positive IgA nephropathy successfully managed with rituximab and mycophenolate mofetil: a case report.

筆者 Yamamoto S, Yoshida S, Higuchi I, Saito K, Temmoku J, Ishikawa T, Watanabe S, Utsumi A, Matsumoto H, Asano T, Sato S, Hashimoto Y, Shimojima Y.
掲載誌  Immunol Med. 2026 May 16:1-8.

Association of elevated serum active IL-18 levels with cytokine profiles and clinical features in adult-onset still's disease.

筆者 Yoshida S, Matsumoto H, Fujita Y, Sumichika Y, Saito K, Asano T, Sato S, Mizokami M, Sugiyama M, Shimojima Y, Kawakami A, Migita K..
掲載誌  Front Immunol. 2026 Apr 28;17:1759584. 

ページの先頭へ戻る